Understanding your kidney tumor in 3D

August 20, 2014 by Melanie Cross, Tulane University
Dr. Jonathan Silberstein holds a replica of a patient’s kidney that was made using a 3D printer. Credit: Paula Burch-Celentano

Most patients rely on their doctors to decipher the black, white and gray images on their CT scans. But what if a patient could instead hold a 3D model made from the CT image in his hands? Suddenly, the picture becomes clearer.

So far, six patients receiving care from the Tulane University Department of Urology have viewed 3D replicas of their kidney cancers prior to .

Ultraviolet lasers are used to print the models in layers using a resin material, similar to plastic. Normal kidney tissue is printed in a clear translucent resin with the tumors in red.

"We can show patients where their tumor is located, how deeply it extends into the , and how we plan to remove it," says Dr. Jonathan Silberstein, chief of the section of urologic oncology.

Until the early 1990s, the standard of care for patients was to remove the entire kidney. Today, many patients have the option of kidney-sparing surgery, through which the tumor is removed, but the healthy portion of the kidney is preserved.

Such organ-sparing surgery may prevent the potential need for dialysis in the future, as well as other issues that could accompany kidney loss.

In addition to the immediate improvement of patient comprehension and assistance in medical trainee education, the models will improve patient outcomes, Silberstein believes.

He says the technology also may be useful for treating other solid-organ cancers, such as liver, lung and prostate cancer. He is applying for a grant to purchase a 3D printer so that the next generation of models can be manufactured in-house.

Explore further: Less radical procedures offer similar cancer control for kidney cancer patients

Related Stories

Less radical procedures offer similar cancer control for kidney cancer patients

August 12, 2014
Needle-guided tumor destruction procedures offer near equivalent lengths of local cancer control compared to surgery for patients with small kidney cancer tumors, according to the results of a large study published in the ...

Study: Kidney cancer patients preserve kidney function with robot-assisted partial nephrectomy

January 13, 2014
Patients with chronic kidney disease who received robot-assisted partial nephrectomy to treat kidney cancer have minimal loss of kidney function—a smaller amount even than patients with normal kidney function, according ...

Robot-assisted technique improves surgeons' ability to remove small kidney cancer tumors

July 11, 2014
Roughly 50,000 Americans are diagnosed with kidney cancer each year. Most of them have small tumors that doctors discover while screening for other health problems.

Low cholesterol linked with worse survival in patients with kidney cancer

June 12, 2014
People are often told to reduce their cholesterol to improve their heart health, but new research suggests that low cholesterol may increase kidney cancer patients' risk of dying from their disease. The findings, which are ...

New Firefly technology lights up more precise kidney sparing surgery

June 5, 2012
A surgical technology called Firefly is shedding new light on kidney cancers and helping doctors at MedStar Georgetown University Hospital remove tumors more safely and more efficiently while sparing the rest of the healthy ...

Gender disparities uncovered in desire to receive living donor kidney transplants

August 14, 2014
Among black kidney failure patients undergoing dialysis, women are much less likely than men to want to receive kidney transplants from living donors, despite more offers from family and friends. The findings, which are from ...

Recommended for you

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.